An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

NCT04971291 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder
Treatment Resistant Depression

Interventions

DRUG: AXS-05
DRUG: Bupropion SR

Sponsor

Axsome Therapeutics, Inc.